Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

8.08
Delayed Data
As of Jul 01
 +0.04 / +0.50%
Today’s Change
5.05
Today|||52-Week Range
9.17
+2.67%
Year-to-Date

Today’s Trading

Previous close8.04
Today’s open8.04
Day’s range8.02 - 8.14
Volume286,736
Average volume (3 months)440,192
Market cap$620.0M
Dividend yield--
Data as of 4:00pm ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+104.76%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book2.91

Competitors

 Today’s
change
Today’s
% change
GNMKGenMark Diagnostics ...+0.35+4.02%
RDNTRadNet Inc+0.05+0.94%
NVTAInvitae Corp+0.21+2.84%
PTIProteostasis Therape...-0.44-3.63%
Data as of 4:01pm ET, 07/01/2016

Financials

Next reporting dateJuly 14, 2016
EPS forecast (this quarter)$0.03
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Operating Officer
Robert J. Shovlin
Corporate headquarters
Fort Myers, Florida

Forecasts

Partner Offers

Search for Jobs